Testing the safety of IMC-003 in healthy postmenopausal women
This study tests the safety of a new medicine called IMC-003. It is for healthy women who have gone through menopause. You may be able to join if you are between 45 and 75 years old and meet certain health criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 45 and 75 years old and have gone through menopause (no period for at least 12 months, or other medical proof).
- You weigh at least 99 pounds (45 kg) and your body mass index (BMI) is between 18.0 and 30.0.
- You are generally healthy, with no major medical conditions like heart disease, bleeding problems, or history of blood clots.
- You are not taking certain medications that affect bone health, such as hormone therapy or vitamin D supplements over 1000 IU daily.
- You have not had cancer, tuberculosis, or a severe allergic reaction to protein drugs before.
- You can avoid smoking, heavy drinking, and excessive caffeine during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how safe and tolerable a new drug, KSHN001034, is in healthy women who have gone through menopause. It involves multiple doses to see how your body processes the medicine.
This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.
This study tests an oral product to see if it can help with menopause symptoms like hot flashes. It is for women aged 40–65 who still have a uterus and are not on hormone therapy.
This trial tests a new drug, TL-001, in healthy volunteers to see if it is safe and how the body processes it. You may join if you are a healthy adult between 18 and 55.
This study tests two devices (BTL-699-2 and HPM-6000UF) to see if they can improve depression symptoms and sexual function in women going through menopause or perimenopause. It may help with mood and intimacy during this life stage.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Hear when a new Healthy Postmenopausal Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.